Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated May 12, 2025, titled "Sun Pharma to announce fourth quarter results on May 22, 2025".
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has informed the exchanges that it will announce its fourth quarter and full-year FY25 financial results on May 22, 2025. The results will be for the quarter and year ended March 31, 2025, and will be made available on the company's website. Senior management will hold a one-hour earnings call at 6:30 PM IST on the same day to discuss performance and take questions from participants. Dial-in numbers and a pre-registration link have been provided, and a transcript will be posted on the website afterwards.
No direct impact on the stock from this notice itself; it simply sets the date for Sun Pharma's Q4 results, which will be the next material catalyst for the stock. Investors should watch May 22, 2025 for actual revenue, margin, and profit numbers that could move the share price.